The Wnt genes encode a large family of secreted protein growth factors that have been identified in animals from hydra to humans. In humans, 19 WNT proteins have been identified that share 27% to 83% amino-acid sequence identity and a conserved pattern of 23 or 24 cysteine residues. Wnt genes are highly conserved between vertebrate species sharing overall sequence identity and gene structure, and are slightly less conserved between vertebrates and invertebrates. During development, Wnts have diverse roles in governing cell fate, proliferation, migration, polarity, and death. In adults, Wnts function in homeostasis, and inappropriate activation of the Wnt pathway is implicated in a variety of cancers. 
In humans, 19 WNT genes have been identified and the chromosomal locations of each is known (see Table 1 ) [1] [2] [3] [4] [5] [6] . Several human WNT genes are located very close to each other in the genome [7, 8] ; these include WNT6 and WNT10a, which are located immediately adjacent to one another on chromosome 2 (about 6.4 kilobases (kb) apart), and WNT1 and WNT10b, which are located adjacent to each other on chromosome 12 (about 8.1 kb apart). WNT6 and WNT10a are transcribed in opposite directions, whereas WNT1 and WNT10b are expressed from the same strand of DNA. Several additional pairs of WNT genes are also clustered within the human genome, including WNT2 and WNT16 (about 4 megabases (Mb) apart), WNT3a and WNT14 (about 250 kb apart), and WNT3 and WNT15. In the mouse, there are at least 18 Wnt genes and the locations of all but two of them have been determined [1-3,5,6]. As in humans, the mouse Wnt1/Wnt10b, Wnt6/Wnt10a, and Wnt3/Wnt15 gene pairs are each located on the same chromosomes, and in the case of the Wnt1/Wnt10b and Wnt6/Wnt10a pairs the close proximity of these genes has been conserved from mouse to human. Interestingly, in the Drosophila genome, the paralogous genes wingless (wg), DWnt6 and DWnt10, are located immediately adjacent to one another on the second chromosome and are all transcribed in the same orientation. Thus, it is possible that there was an ancient cluster of Wnt genes consisting of Wnt1, Wnt6 and Wnt10 in a common ancestor of vertebrates and arthropods. In vertebrates, this cluster may have been duplicated with subsequent loss of Wnt1 from one cluster and Wnt6 from the other.
The majority of human WNT genes contain four coding exons, with exon 1 containing the initiation methionine ( Figure 1a ) [8] . WNT genes that differ from this pattern include WNT14, with three exons, WNT2, WNT5b, and WNT11, with five exons, and WNT8b with six exons. Several WNTs -WNT2b/13, WNT8a/d, and WNT16 -have alternative amino or carboxyl termini, which result from the use of alternative 5? or 3? exons.
Evolutionary history
The deduced evolutionary relationships of 18 of the 19 known human WNT genes are shown in Figure 2 . The majority of Wnt proteins share about 35% amino-acid sequence identity, although members of a subgroup (those with the same numeral, such as WNT3 and WNT3a) share increased sequence identity (from 58% to 83%) and some overlapping sites of expression. Members of subgroups are not closely linked within the genome, however, suggesting that they were generated by gene-translocation or genomeduplication events, not by local duplication events.
Wnt genes have been identified in vertebrates and invertebrates, but appear to be absent from plants, unicellular eukaryotes such as Saccharomyces cerevisiae and from prokaryotes. To date, in vertebrates, 16 Wnt genes have been identified in Xenopus, 11 in chick, and 12 in zebrafish [5] ; in invertebrates, Drosophila has seven Wnt genes, Caenorhabditis elegans five and Hydra at least one [5] . The apparent evolutionary relationships between selected invertebrate and vertebrate Wnt genes are shown in Figure 2b . In vertebrates, the orthologs in different species are highly similar in sequence. For example, human WNT1 and mouse Wnt1 are 98% identical, and human WNT5a and Xenopus Wnt5a are 84% identical at the amino-acid level. Phylogenetic analyses of vertebrate and invertebrate Wnts demonstrate orthologous relationships between several human and Drosophila Wnts (Figure 2b ). The sequence identity between orthologous proteins in humans and flies ranges from 21% between human WNT8a/d and Drosophila DWnt8 to 42% sequence identity between human WNT1 and Drosophila Wingless (Wg). The evolutionary relationship between the five C. elegans Wnt genes and human WNT genes is less apparent, making it difficult to determine which C. elegans Wnt genes may have orthologs in the human genome.
Characteristic structural features
Human WNT proteins are all very similar in size, ranging in molecular weight from 39 kDa (WNT7a) to 46 kDa (WNT10a) [3] . Drosophila Wnt proteins are also similar to this, with the exception of Wg, which is approximately 54 kDa and has an internal insert not found in vertebrate Wnts, and DWnt3/5, which is about 112 kDa [3] . Very little is known about the structure of Wnt proteins, as they are notoriously insoluble, but all have 23 or 24 cysteine residues, the spacing of which is highly conserved (Figure 1b) , suggesting that Wnt protein folding may depend on the formation of multiple intramolecular disulfide bonds. Analysis of the signaling activities of chimeric Wnt proteins has shown that the carboxy-terminal region of Wnt proteins may play a role in determining the specificity of responses to different Wnts [9] . Furthermore, deletion mutants lacking the carboxy-terminal third of a Wnt protein can act as 
Intracellular signaling pathways
Wnt signals are transduced through at least three distinct intracellular signaling pathways including the canonical 'Wnt/--catenin' pathway, the 'Wnt/Ca 2+ ' pathway, and the 'Wnt/polarity' pathway (also called the 'planar polarity' pathway) [5, [56] [57] [58] [59] [60] [61] [62] . Distinct sets of Wnt and Fzd ligandreceptor pairs can activate each of these pathways and lead to unique cellular responses. The Wnt/--catenin pathway primarily regulates cell fate determination during development, whereas the major function of the Wnt/polarity pathway is regulation of cytoskeletal organization. The biological function of the Wnt/Ca 2+ pathway is unclear.
The canonical Wnt/--catenin pathway is intensely studied, and on the basis of current literature I propose the model illustrated in Figure 3a In the Wnt/--catenin pathway, Wnt signaling depends on the steady-state levels of the multi-functional protein --catenin. In the absence of Wnt signal, a multi-protein destruction complex that includes the adenomatous polyposis coli protein (APC) and a member of the Axin family facilitates the phosphorylation of --catenin by glycogen synthase kinase 3 (GSK3). GSK3 substrates also include APC and Axin; phosphorylation of each of these proteins leads to enhanced binding of --catenin. Phosphorylated --catenin is bound by the F-box protein --TrCP, a component of an E3 ubiquitin ligase complex, and is ubiquitinated; the ubiquitin tag marks --catenin for destruction by the proteasome. When a cell is exposed to a Wnt, the Wnt interacts with its coreceptors Frizzled and LRP. Activation of Frizzled and LRP leads to the phosphorylation of Dishevelled (Dsh), a cytoplasmic scaffold protein, perhaps through stimulation of casein kinase I0 (CKI0) and/or casein kinase II (CKII). Dsh then functions through its interaction with Axin to antagonize GSK3, preventing the phosphorylation and ubiquitination of --catenin. In vertebrates, inhibition of GSK3 may involve the activity of GSK3 binding protein (GBP/Frat ), which binds to both Dsh and GSK3 and can promote dissociation of GSK3 from the destruction complex. Unphosphorylated --catenin escapes degradation, accumulates in the cell, and enters the nucleus, where it interacts with members of the TCF/LEF family of HMG-domain transcription factors to stimulate expression of target genes. In addition to the components of the Wnt/--catenin pathway described here, many additional proteins with potential roles in regulating Wnt/--catenin signaling have been reported including the phosphatase PP2A and the kinases Akt/protein kinase B, integrin-linked kinase (ILK), and PKC. (b) Signaling through the Wnt/Ca 2+ pathway appears to involve activation of the two pertussis-toxin-sensitive G proteins, G ,o and G ,t , in combination with G -2 [34,35]. G-protein activation then leads to an increase in intracellular Ca 2+ and the subsequent stimulation of Ca 2+ /calmodulin-dependent kinase II (CamKII) [37] . Activation of the Wnt/Ca 2+ pathway also results in stimulation of PKC activity in the form of the translocation of PKC to the plasma membrane [34] . Downstream targets of the Wnt/Ca2 + pathway have not been identified. (c) The Wnt/polarity pathway, which regulates cytoskeletal organization; the Drosophila Wnt/polarity pathway that regulates the polarity of trichomes in the wing is shown as an example. In this case, the nature of the polarity signal is not known. 
Important mutants and developmental functions
Loss-of-function mutations in 9 of the 18 mouse Wnt genes have been generated, and the phenotypes of mutant embryos demonstrate the diverse functions of Wnt genes during embryogenesis ( 
Wnt signaling and cancer
In addition to the many roles for Wnt signaling during development and in adult tissues, it is also involved in tumorigenesis in humans [59, 64] . Although mutation or misexpression of a Wnt gene has not been linked directly to cancer in humans, mutation of several intracellular components of the Wnt/--catenin pathway is thought to be critical in many forms of cancer. Most notably, patients with familial adenomatous polyposis (FAP) develop multiple intestinal adenomas early in life and have germline mutations in the APC gene. In addition, mutation of APC is associated with more than 80% of sporadic colorectal adenomas and carcinomas. More than 95% of germline and somatic mutations of the APC gene are nonsense mutations that result in the synthesis of a truncated protein lacking the region of APC that is important for its function in the destruction complex. Significantly, these truncations in APC remove binding sites for --catenin and Axin, as well as putative phosphorylation sites for GSK3; as a result, the mutant APC protein cannot efficiently promote degradation of --catenin. Mutations in the third exon of the human --catenin gene (CTNNb1) that make it refractory to phosphorylation-dependent degradation and 
